Диссертация (1140838), страница 19
Текст из файла (страница 19)
80(2). — P. 411–417.80. Lainscak, M. How to improve adherence to life-saving heart failure treatments withpotassium binders / M. Lainscak // Card Fail Rev. — 2017. — Vol. 3(1).— P. 33–39.81. Lang, R. M.Recommendationsforcardiacchamberquantificationbyechocardiography in adults: an update from the American Society ofEchocardiography and the European Association of Cardiovascular Imaging/ R.
M. Lang, L. P. Badano, V. Mor-Avi [et al.] // J Am Soc Echocardiogr. — 2015.— Vol. 28(1). — P. 1–39.e14.82. Laposata, M. Laboratory medicine. The diagnosis of disease in the clinicallaboratory / Y. P. Agrawal, S. L. Aleryani, D. N. Alter [et al.]. Ed. by M. Laposata.— 2th ed. — China : McGraw-Hill Education, 2014. — 512 p.12083. Lee, D. S. Design and rationale for the acute congestive heart failure urgent careevaluation: the ACUTE study / D. S.
Lee, J. S. Lee, M. J. Schull [et al.] // AmHeart J. — 2016. — Vol. 181. — P. 60–65.84. Legrand, M. Association between hypo- and hyperkalemia and outcome in acuteheart failure patients: the role of medications / M. Legrand, P. O. Ludes, Z. Massy[et al.] // Clin Res Cardiol. — 2018. — Vol.
107(3). — P. 214–221.85. Levin, A. KDIGO 2012 clinical practice guideline for the evaluation andmanagement of chronic kidney disease / Kidney Disease: Improving GlobalOutcomes (KDIGO) CKD Work Group // Kidney Int Suppl. — 2013. — Vol. 3(1).— P. 1–150.86. Lindner, G.
Störungen des natriumhaushalts beim notfallpatienten / G. Lindner,A. K. Exadaktylos // Anaesthesist. — 2013. — Vol. 62(4). — P. 296–303.87. Maggioni, A. P. EURObservational Research Programme: the Heart Failure PilotSurvey (ESC-HF Pilot) / A. P. Maggioni, U. Dahlström, G.
Fillipatos [et al.] // EurJ Heart Fail. — 2010. — Vol. 12(10). — P. 1076–1084.88. Martín-Sánchez, F. J. The effect of frailty on 30-day mortality risk in older patientswithacuteheartfailureattendedintheemergencydepartment/ F. J. Martín-Sánchez, E. Rodríguez-Adrada, C. Mueller [et al.] // Acad EmergMed. — 2017. — Vol. 24(3). — P. 298–307.89. Mentz, R.
J. Torsemide versus furosemide in patients with acute heart failure (fromthe ASCEND-HF trial) / R. J. Mentz, V. Hasselblad, A. D. DeVore [et al.] // Am JCardiol. — 2016. — Vol. 117(3). — P. 404–411.90. Meyer, S. Sex-specific acute heart failure phenotypes and outcomes fromPROTECT / S. Meyer, P. van der Meer, B. M. Massie [et al.] // Eur J Heart Fail.— 2013.
— Vol. 15(12). — P. 1374–1381.12191. Mohan, S. Prevalence of hyponatremia and association with mortality: results fromNHANES / S. Mohan, S. Gu, A. Parikh, J. Radhakrishnan // Am J Med. — 2013.— Vol. 126(12). — P. 1127–1137.e1.92. Nieminen, M. S. EuroHeart Failure Survey II (EHFS II): a survey on hospitalizedacute heart failure patients: description of population / M. S. Nieminen,D. Brutsaert, K. Dickstein [et al.] // Eur Heart J.
— 2006. — Vol. 27(22).— P. 2725–2736.93. Núňez, J. Long-term potassium monitoring and dynamics in heart failure and riskof mortality / J. Núňez, A. Bayés-Genís, F. Zannad [et al.] // Circulation. — 2018.— Vol. 137(13). — P. 1320–1330.94. Patra, S. Short term efficacy and safety of low dose tolvaptan in patients with acutedecompensated heart failure with hyponatremia: a prospective observational pilotstudy from a single center in South India / S. Patra, B. Kumar, K. K.
Harlalka[et al.] // Heart Views. — 2014. — Vol. 15(1). — P. 1–5.95. Pitt, B. Serum potassium in patients with chronic heart failure: once we make aU-turn where should we go? / B. Pitt, P. Rossignol // Eur Heart J. — 2017.— Vol. 38(38). — P. 2897–2899.96. Price, J. F.Incidence, severity, and association with adverse outcome ofhyponatremia in children hospitalized with heart failure / J. F.
Price, P. F. Kantor,R. E. Shaddy [et al.] // Am J Cardiol. — 2016. — Vol. 118(7). — P. 1006–1010.97. R: a language and environment for statistical computing [Electronic data andprogram] / R Development Core Teem (2011) // R Foundation for StatisticalComputing, Vienna, Austria. — 2011. — URL:http://www.R-project.org.98.
Rastegar, A. Serum potassium / A. Rastegar // Clinical methods. The history,physical, and laboratory examinations / Ed. by H. K. Walker, W. D. Hall. J. W.Hurst — 3th ed. —Boston : Butterworths, 1990. — P 884-887.12299. Reeves, G. R. Rehabilitation Therapy in Older Acute Heart Failure Patients(REHAB-HF) trial: design and rationale / G. R.
Reeves, D. J. Whellan, P. Duncan[et al.] // Am Heart J. — 2017. — Vol. 185. — P. 130–139.100. Rothman, K. J. BMI-related errors in the measurement of obesity / K. J. Rothman// Int J Obes (Lond). — 2008. — Vol. 32(Suppl 3). — P. S56–S59.101. Rusinaru, D. Relationship of serum sodium concentration to mortality in a widespectrum of heart failure patients with preserved and with reduced ejectionfraction: an individual patient data meta-analysis† / Meta-Analysis Global Group inChronic heart failure (MAGGIC) // Eur J Heart Fail. — 2012.
— Vol. 14(10).— P. 1139–1146.102. Salah, K. Serum potassium decline during hospitalization for acute decompensatedheart failure is a predictor of 6-month mortality, independent of N-terminal pro-Btype natriuretic peptide levels: an individual patient data analysis / K. Salah,Y. M. Pinto, L. W. Eurlings [et al.] // Am Heart J. — 2015. — Vol. 170(3).— P. 531–542.e1.103. Sarwar, C.
M. Hyperkalemia in heart failure / C. M. Sarwar, L. Papadimitriou,B. Pitt [et al.] // J Am Coll Cardiol. — 2016. — Vol. 68(14). — P. 1575–1589.104. Sarwar, C. M. S. Role of hyperkalemia in heart failure and the therapeutic use ofpotassium binders / C. M. S. Sarwar, A. A. Bhagat, S. D. Anker, J. Butler // HandbExp Pharmacol.
— 2017. — Vol. 243. — P. 537–560.105. Sato, N. Acute decompensated heart failure syndromes (ATTEND) registry. Aprospective observational multicenter cohort study: rationale, design, andpreliminary data / N. Sato, K. Kajimoto, K. Asai [et al.] // Am Heart J. — 2010.— Vol. 159(6). — P. 949–955.106. Schwinger, R. H.
Heart failure and electrolyte disturbances / R. H. Schwinger,E. Erdmann // Methods Find Exp Clin Pharmacol. — 1992. — Vol. 14(4).— P. 315–325.123107. Setoguchi, S. Repeated hospitalizations predict mortality in the communitypopulation with heart failure / S. Setoguchi L. W.
Stevenson, S. Schneeweiss // AmHeart J. — 2007. — Vol. 154(2). — P. 260–266.108. Sica, D. A. Hyperkalemia, congestive heart failure, and aldosterone receptorantagonism / D. A. Sica, T. W. Gehr, C. Yancy // Congest Heart Fail. — 2003.— Vol. 9(4). — P. 224–229.109. Soliman, E. Z. Usefulness of maintaining a normal electrocardiogram over time forpredicting cardiovascular health / E. Z. Soliman, Z. M. Zhang, L.
Y. Chen[et al.] // Am J Cardiol. — 2017. — Vol. 119(2). — P. 249–255.110. Sudharshan, S. Use of biomarkers to predict readmission for congestive heartfailure / S. Sudharshan, E. Navak, K. Hock [et al.] // Am J Cardiol. — 2017.— Vol. 119(3). — P. 445–451.111. Suzuki, S. Vasopressin V2 receptor antagonist tolvaptan is effective in heart failurepatients with reduced left ventricular systolic function and low blood pressure/ S.
Suzuki, A. Yoshihisa, T. Yamaki [et al.] // Int Heart J. — 2015. — Vol. 56(2).— P. 213–218.112. Teerlink, J. R. Acutedecompensated heart failure update / J. R. Teerlink,K. Alburikan, M. Metra, J. E. Rodgers // Curr Cardiol Rev. — 2015. — Vol. 11(1).— P. 53–62.113. Thomsen, R. W.
Elevated potassium levels in patients with congestive heart failure:occurrence, risk factors, and clinical outcomes. A Danish population-based cohortstudy [Electronic resource] / R. W. Thomsen, S. K. Nicolaisen, P. Hasvold [et al.] //JAmHeartAssoc.— 2018.— Vol. 7(11).— P.
e008912.— doi:10.1161/JAHA.118.008912114. Tromp, J. Serum potassium levels and outcome in acute heart failure (data from thePROTECT and COACH trials) / J. Tromp, J. M. Ter Maaten, K. Damman[et al.] // Am J Cardiol. — 2017. — Vol. 119(2). — P. 290–296.124115. Tymińska, A. Anemia at hospital admission and its relation to outcomes in patientswith heart failure (from the Polish Cohort of 2 European Society of CardiologyHeart Failure Registries) / A. Tymińska, A. Kaplon-Cieślicka, K. Ozierański [et al.]// Am J Cardiol. — 2017. — Vol. 119(12).
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
